BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29884173)

  • 1. Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome.
    Murphy MM; Lindsey Burrell T; Cubells JF; España RA; Gambello MJ; Goines KCB; Klaiman C; Li L; Novacek DM; Papetti A; Sanchez Russo RL; Saulnier CA; Shultz S; Walker E; Mulle JG
    BMC Psychiatry; 2018 Jun; 18(1):183. PubMed ID: 29884173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.
    Pollak RM; Murphy MM; Epstein MP; Zwick ME; Klaiman C; Saulnier CA; ; Mulle JG
    Mol Autism; 2019; 10():30. PubMed ID: 31346402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report.
    Murphy MM; Burrell TL; Cubells JF; Epstein MT; Espana R; Gambello MJ; Goines K; Klaiman C; Koh S; Russo RS; Saulnier CA; Walker E; ; Mulle JG
    BMC Psychiatry; 2020 Apr; 20(1):184. PubMed ID: 32321479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel features of 3q29 deletion syndrome: Results from the 3q29 registry.
    Glassford MR; Rosenfeld JA; Freedman AA; Zwick ME; Mulle JG;
    Am J Med Genet A; 2016 Apr; 170A(4):999-1006. PubMed ID: 26738761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series.
    Malt EA; Juhasz K; Frengen A; Wangensteen T; Emilsen NM; Hansen B; Agafonov O; Nilsen HL
    Mol Genet Genomic Med; 2019 Sep; 7(9):e889. PubMed ID: 31347308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients.
    Città S; Buono S; Greco D; Barone C; Alfei E; Bulgheroni S; Usilla A; Pantaleoni C; Romano C
    Am J Med Genet A; 2013 Dec; 161A(12):3018-22. PubMed ID: 24214349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care.
    Sanchez Russo R; Gambello MJ; Murphy MM; Aberizk K; Black E; Burrell TL; Carlock G; Cubells JF; Epstein MT; Espana R; Goines K; Guest RM; Klaiman C; Koh S; Leslie EJ; Li L; Novacek DM; Saulnier CA; Sefik E; Shultz S; Walker E; White SP; ; Mulle JG
    Genet Med; 2021 May; 23(5):872-880. PubMed ID: 33564151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel 3q29 deletion associated with autism, intellectual disability, psychiatric disorders, and obesity.
    Biamino E; Di Gregorio E; Belligni EF; Keller R; Riberi E; Gandione M; Calcia A; Mancini C; Giorgio E; Cavalieri S; Pappi P; Talarico F; Fea AM; De Rubeis S; Cirillo Silengo M; Ferrero GB; Brusco A
    Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):290-9. PubMed ID: 26620927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Musculoskeletal phenotypes in 3q29 deletion syndrome.
    Pollak RM; Tilmon JC; Murphy MM; Gambello MJ; Sanchez Russo R; Dormans JP; Mulle JG
    Am J Med Genet A; 2023 Nov; 191(11):2749-2756. PubMed ID: 37691301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.
    Baba M; Yokoyama K; Seiriki K; Naka Y; Matsumura K; Kondo M; Yamamoto K; Hayashida M; Kasai A; Ago Y; Nagayasu K; Hayata-Takano A; Takahashi A; Yamaguchi S; Mori D; Ozaki N; Yamamoto T; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Neuropsychopharmacology; 2019 Nov; 44(12):2125-2135. PubMed ID: 31216562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New phenotypes associated with 3q29 duplication syndrome: Results from the 3q29 registry.
    Pollak RM; Zinsmeister MC; Murphy MM; Zwick ME; ; Mulle JG
    Am J Med Genet A; 2020 May; 182(5):1152-1166. PubMed ID: 32154651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities.
    D'Angelo D; Lebon S; Chen Q; Martin-Brevet S; Snyder LG; Hippolyte L; Hanson E; Maillard AM; Faucett WA; Macé A; Pain A; Bernier R; Chawner SJ; David A; Andrieux J; Aylward E; Baujat G; Caldeira I; Conus P; Ferrari C; Forzano F; Gérard M; Goin-Kochel RP; Grant E; Hunter JV; Isidor B; Jacquette A; Jønch AE; Keren B; Lacombe D; Le Caignec C; Martin CL; Männik K; Metspalu A; Mignot C; Mukherjee P; Owen MJ; Passeggeri M; Rooryck-Thambo C; Rosenfeld JA; Spence SJ; Steinman KJ; Tjernagel J; Van Haelst M; Shen Y; Draganski B; Sherr EH; Ledbetter DH; van den Bree MB; Beckmann JS; Spiro JE; Reymond A; Jacquemont S; Chung WK; ; ;
    JAMA Psychiatry; 2016 Jan; 73(1):20-30. PubMed ID: 26629640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A distinct cognitive profile in individuals with 3q29 deletion syndrome.
    Klaiman C; White SP; Saulnier C; Murphy M; Burrell L; Cubells J; Walker E; ; Mulle JG
    J Intellect Disabil Res; 2023 Mar; 67(3):216-227. PubMed ID: 35297118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying a failure-to-thrive fraternal twin profile with 3q29 deletion syndrome.
    Capps C; Nemeth DG; Olivier TW; Felix SD
    Appl Neuropsychol Child; 2024; 13(1):84-91. PubMed ID: 37480577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion.
    Sagar A; Bishop JR; Tessman DC; Guter S; Martin CL; Cook EH
    Am J Med Genet A; 2013 Apr; 161A(4):845-9. PubMed ID: 23443968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial inheritance of the 3q29 microdeletion syndrome: case report and review.
    Khan WA; Cohen N; Scott SA; Pereira EM
    BMC Med Genomics; 2019 Mar; 12(1):51. PubMed ID: 30885185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review.
    Quintero-Rivera F; Sharifi-Hannauer P; Martinez-Agosto JA
    Am J Med Genet A; 2010 Oct; 152A(10):2459-67. PubMed ID: 20830797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.
    Rutkowski TP; Purcell RH; Pollak RM; Grewenow SM; Gafford GM; Malone T; Khan UA; Schroeder JP; Epstein MP; Bassell GJ; Warren ST; Weinshenker D; Caspary T; Mulle JG
    Mol Psychiatry; 2021 Mar; 26(3):772-783. PubMed ID: 30976085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
    Bassett AS; Lowther C; Merico D; Costain G; Chow EWC; van Amelsvoort T; McDonald-McGinn D; Gur RE; Swillen A; Van den Bree M; Murphy K; Gothelf D; Bearden CE; Eliez S; Kates W; Philip N; Sashi V; Campbell L; Vorstman J; Cubells J; Repetto GM; Simon T; Boot E; Heung T; Evers R; Vingerhoets C; van Duin E; Zackai E; Vergaelen E; Devriendt K; Vermeesch JR; Owen M; Murphy C; Michaelovosky E; Kushan L; Schneider M; Fremont W; Busa T; Hooper S; McCabe K; Duijff S; Isaev K; Pellecchia G; Wei J; Gazzellone MJ; Scherer SW; Emanuel BS; Guo T; Morrow BE; Marshall CR;
    Am J Psychiatry; 2017 Nov; 174(11):1054-1063. PubMed ID: 28750581
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.